These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37517951)

  • 1. Mortality and cardiovascular risk in vasculitis ANCA. Importance of hypertension and renal function. Experience from southern Spain.
    Martin-Gómez MA; Rodríguez Torres A; Espinosa Hernández M; Lopez Mendoza M; Sabio Sánchez JM; Martin Armada M; Martin Suarez I; Callejas Rubio JL; Castilla Castellano MM; Anglada Pintado JC; Barnosi Marín AC; Martinez Esteban MD; Castilla Guerra L; De Ramón Garrido E;
    Hipertens Riesgo Vasc; 2024; 41(1):5-16. PubMed ID: 37517951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The BVAS is an independent predictor of cardiovascular events and cardiovascular disease-related mortality in patients with ANCA-associated vasculitis: A study of 504 cases in a single Chinese center.
    Bai YH; Li ZY; Chang DY; Chen M; Kallenberg CG; Zhao MH
    Semin Arthritis Rheum; 2018 Feb; 47(4):524-529. PubMed ID: 28917713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the risk factors for end‑stage renal disease and mortality in ANCA-associated vasculitis: a study from a single center of the Chinese Rheumatism Data Center.
    Guo Q; Yu L; Zhang X; Shang J; Duan X
    Clin Rheumatol; 2023 Feb; 42(2):489-499. PubMed ID: 36367596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.
    Yoo BW; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Rheumatol; 2020 Mar; 39(3):831-840. PubMed ID: 31802348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of protein A immunoadsorption and therapeutic plasma exchange in ANCA-associated vasculitis with severe renal involvement: a retrospective study.
    Liu X; Xia M; Liu D; Liu H; Tang C; Chen G; Liu Y; Yuan F; Liu H
    Ann Med; 2023 Dec; 55(1):2230875. PubMed ID: 37452682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlling Nutritional Status Score is Associated with All-Cause Mortality in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Yonsei Med J; 2019 Dec; 60(12):1164-1173. PubMed ID: 31769247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study.
    Yang L; Xie H; Liu Z; Chen Y; Wang J; Zhang H; Ge Y; Hu W
    BMC Nephrol; 2018 Jun; 19(1):138. PubMed ID: 29902982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study.
    Fonseca JA; Gameiro J; Duarte I; Jorge S; Lopes JA
    Nefrologia (Engl Ed); 2021; 41(3):321-328. PubMed ID: 36165341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traditional and Disease-Specific Risk Factors for Cardiovascular Events in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Multinational Retrospective Study.
    Moiseev S; Bulanov N; Crnogorac M; Direskeneli H; Galesic K; Gazel U; Geetha D; Guillevin L; Hrušková Z; Little MA; O'Neill L; Makarov E; McAdoo SP; Mohammad AJ; Moran S; Novikov P; Pusey CD; Rahmattulla C; Satrapová V; Silva J; Suvorov A; Tesar V; Terrier B; Willeit P; Zhao MH; Kronbichler A; Jayne DRW
    J Rheumatol; 2023 Sep; 50(9):1145-1151. PubMed ID: 36642436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphopaenia at diagnosis of anti-neutrophil cytoplasmic antibody-vasculitis with renal involvement is correlated with severity and renal prognosis.
    Wacrenier S; Riou J; Jourdain P; Guibert F; Henry N; Djema A; Coindre JP; Crochette R; Cousin M; Croue A; Subra JF; Piccoli G; Augusto JF; Brilland B
    Nephrol Dial Transplant; 2022 May; 37(6):1078-1087. PubMed ID: 33856482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineutrophil cytoplasmic antibody-associated vasculitis classification by cluster analysis based on clinical phenotypes: a single-center retrospective cohort study.
    Lee LE; Pyo JY; Ahn SS; Song JJ; Park YB; Lee SW
    Clin Rheumatol; 2024 Jan; 43(1):367-376. PubMed ID: 37530864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing incidence and improved survival in ANCA-associated vasculitis-a Danish nationwide study.
    Nelveg-Kristensen KE; Szpirt W; Carlson N; McClure M; Jayne D; Dieperink H; Gregersen JW; Krarup E; Ivarsen P; Torp-Pedersen C; Egfjord M
    Nephrol Dial Transplant; 2021 Dec; 37(1):63-71. PubMed ID: 33313875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinuria and hematuria after remission induction are associated with outcome in ANCA-associated vasculitis.
    Benichou N; Charles P; Terrier B; Jones RB; Hiemstra T; Mouthon L; Bajema I; Berden A; Thervet E; Guillevin L; Jayne D; Karras A;
    Kidney Int; 2023 Jun; 103(6):1144-1155. PubMed ID: 36940799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type.
    Wallace ZS; Fu X; Harkness T; Stone JH; Zhang Y; Choi H
    Rheumatology (Oxford); 2020 Sep; 59(9):2308-2315. PubMed ID: 31846030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Cardiovascular Disease and Venous Thromboembolism Among Patients With Incident ANCA-Associated Vasculitis: A 20-Year Population-Based Cohort Study.
    Berti A; Matteson EL; Crowson CS; Specks U; Cornec D
    Mayo Clin Proc; 2018 May; 93(5):597-606. PubMed ID: 29588079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes.
    Monti S; Craven A; Klersy C; Montecucco C; Caporali R; Watts R; Merkel PA; Luqmani R;
    Rheumatology (Oxford); 2021 Feb; 60(2):617-628. PubMed ID: 32447389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The initial predictors of death in 153 patients with ANCA-associated vasculitis in a single Korean centre.
    Mun CH; Yoo J; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2018; 36 Suppl 111(2):65-72. PubMed ID: 29465370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased renal damage in hypocomplementemic patients with ANCA-associated vasculitis: retrospective cohort study.
    García L; Pena CE; Maldonado RÁ; Costi C; Mamberti M; Martins E; García MA
    Clin Rheumatol; 2019 Oct; 38(10):2819-2824. PubMed ID: 31222573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of cardiovascular disease preceding diagnosis of incident ANCA-associated vasculitis: a Danish nationwide study.
    Nygaard L; Polcwiartek C; Nelveg-Kristensen KE; Carlson N; Kristensen S; Torp-Pedersen C; ; Gregersen JW
    Rheumatology (Oxford); 2024 May; 63(5):1313-1321. PubMed ID: 37481712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-Reactive Protein to Serum Albumin Ratio Is an Independent Predictor of All-Cause Mortality in Patients with ANCA-Associated Vasculitis.
    Moon JS; Ahn SS; Park YB; Lee SK; Lee SW
    Yonsei Med J; 2018 Sep; 59(7):865-871. PubMed ID: 30091320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.